Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

Anthem Biosciences IPO listing was in line with the Street estimates as indicated by the grey market premium (GMP). Anthem ...

Anthem Biosciences had a robust launch on the stock exchanges today. On the NSE, the stock began trading at ₹723.05 each, ...

Anthem Biosciences shares listed at ₹723.10 per share on the BSE and ₹723.05 per share on the NSE, compared to the issue ...

Analysts said that Anthem Biosciences' IPO was fairly priced, supported by strong growth, industry-leading margins, and ...

Key Details and Listing Information<br />The bidding for the Anthem Biosciences Initial Public Offering (IPO) took place from ...

Contract research, development, and manufacturing organisation Anthem Biosciences shares recorded healthy returns on its ...

Street debut on Monday, July 21, 2025. Here's what the current grey market trends hint at regarding the company's possible ...

Market experts anticipate the stock to list at a premium of up to 25 percent over its issue price, driven by the company’s ...

Anthem Biosciences made a modest debut on Dalal Street, listing nearly 27% above its IPO price. Here's what you need to know ...

Anthem Biosciences Ltd. made a stellar debut in the secondary market with a premium of 27% over its IPO price. The scrip was ...

Ahead of its listing, Anthem Biosciences was commanding a strong grey market premium (GMP) of ₹179 in the unlisted market, ...